Urticarial vasculitis after meningococcal serogroup B vaccine in a 6‐year‐old girl - Velasco‐Tamariz - 2018 - Pediatric Dermatology - Wiley Online Library
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program - ScienceDirect
PDF) Kawasaki disease incidence in children and adolescents: An observational study in primary care
AUSTRALIAN PRODUCT INFORMATION BEXSERO (multicomponent meningococcal group b vaccine) suspension for injection 1 NAME OF THE
Bexsero Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Package leaflet: information for the user Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine
In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines | Scientific Reports
Bexsero, common name - meningococcal group B Vaccine (rDNA, component, adsorbed)
Components of the Bexsero Vaccine. | Download Scientific Diagram
Frontiers | The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention | Immunotherapy
Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
PDF) Post-licensure observational safety study after meningococcal B Vaccine (4CMenB) vaccination in routine UK care DOI10.1002/pds.5114
Vacuna del meningococo B, y tetravalente meningococos ACWY. | Consultas Frecuentes | Tu Pediatra Online
Bexsero - NPS MedicineWise
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination - ScienceDirect
MENINGOCOCCAL GROUP B VACCINE (BEXSERO) Information for Health Professionals
Bexsero - NPS MedicineWise
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program - ScienceDirect
Physicians for Informed Consent - Did you know that Bexsero Meningococcal B vaccine may predispose children towards Kawasaki disease? Listed under Possible Side Effects: “Rare (these may affect up to 1 in
Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience | Archives of Disease in Childhood
In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines | Scientific Reports
Bexsero - NPS MedicineWise
The risk of Kawasaki disease after pneumococcal conjugate & meningococcal B vaccine in England: A self-controlled case-series analysis - ScienceDirect
Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis - The Lancet Infectious Diseases
